Nanomedicine For Drug Delivery Market
Nanomedicine for Drug Delivery Market Forecasts to 2030 - Global Analysis By Product Type (Nanoparticles, Nanoshells, Nanodevices and Nanotubes), Modality (Treatments and Diagnostics), Indication, Route of Administration, End User and By Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $197.6 BN |
|
Projected Year Value (2030) |
US $479.4 BN |
|
CAGR (2023 - 2030) |
13.5% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
North America |
|
Highest Growing Market |
Europe |
According to Stratistics MRC, the Global Nanomedicine for Drug Delivery Market is accounted for $197.6 billion in 2023 and is expected to reach $479.4 billion by 2030 growing at a CAGR of 13.5% during the forecast period. The field of medicine known as ""nanomedicine"" employs instruments and expertise in nanotechnology to prevent and cure various illnesses. Nanoparticles can be engineered to target specific cells or tissues, reducing side effects and increasing the drug's effectiveness by delivering it directly to the intended site. Nanoparticles can extend a drug's circulation time in the body, allowing for a sustained release of medication and reducing the frequency of dosing.
According to American Cancer Society, it is estimated in 2023, about 297,790 new cases of invasive breast cancer will be diagnosed in women in U.S. Nanoparticles, nanocarriers, and other nanoscale drug delivery platforms offer unique properties that enhance drug stability, solubility, bioavailability, and control over release kinetics.
Market Dynamics:
Driver:
Rising prevalence of chronic diseases
Chronic illnesses, including diabetes, heart disease, and cancer, are becoming more common. Nanomedicine-based drug delivery systems have shown promising results in improving the efficacy of therapeutic agents for these conditions. Treating chronic diseases has become more appealing for nanoparticles due to their capacity to target particular cells or tissues and deliver drugs directly to the site of action. The need for nanomedicine in drug delivery rises with the prevalence of these diseases.
Restraint:
Safety concerns
While nanomedicine offers numerous benefits, there are concerns regarding the safety of nanoparticles. Nanoparticles' small size and special physicochemical characteristics raise the possibility of unforeseen biological interactions and toxicity. The long-term effects of nanoparticle exposure and accumulation in the body are still being studied. The market's acceptance of nanomedicine products can be affected by safety concerns.
Opportunity:
Technological advancements in imaging and diagnostics
In diagnostic imaging methods like computed tomography (CT), positron emission tomography (PET), and magnetic resonance imaging (MRI), nanomedicine is essential. It is possible to engineer nanoparticles to carry imaging agents, improving disease detection and visualization. The integration of diagnostic and therapeutic functions in nanoparticles allows for theranostic applications, where diagnosis and treatment can be combined. The expansion of the nanomedicine drug delivery market has been facilitated by developments in imaging and diagnostics.
Threat:
Manufacturing scalability
Products involving nanomedicines can have complicated manufacturing processes requiring specialized facilities and machinery. There are many obstacles to overcome when increasing production while preserving the cost-effectiveness, consistency, and quality of the final product. The production of nanomedicine products frequently entails the complex and time-consuming processes of synthesizing, purifying, and characterizing nanoparticles. Advanced technologies and expertise are needed to produce nanoparticles with precise size, shape, and surface characteristics. Therefore, manufacturing scalability is a significant factor hampering market demand.
Covid-19 Impact
The COVID-19 pandemic profoundly affected the nanomedicine for drug delivery market. Disruptions in the global supply chain led to shortages of essential components, hindering the production of nanomedicine. Clinical trials for new applications faced delays or halts due to restrictions on in-person interactions, impacting research progress. Market demand fluctuated as the focus turned toward targeted drug delivery systems and remote healthcare solutions, highlighting the importance of adaptable and precise drug delivery mechanisms. The pandemic accelerated the adoption of telemedicine and remote patient monitoring, influencing the demand for drug delivery systems that support these new healthcare approaches.
The nanoshells segment is expected to be the largest during the forecast period
The nanoshells segment is estimated to hold the largest share. These are core-shell nanoparticles, with a thin metallic shell (usually made of silver or gold) encircling a dielectric core. Because of their special structure, their optical characteristics, namely, their capacity to scatter and absorb light, can be precisely controlled. Nanoshells are designed to carry and administer therapeutic agents to particular target areas within the body when it comes to drug delivery. It is possible to adjust their size and surface characteristics to maximize interactions with biological tissues. Additionally, they can also react to particular light wavelengths due to their metallic shell, which is an essential characteristic for targeted therapy and controlled drug release.
The oncological diseases segment is expected to have the highest CAGR during the forecast period
The oncological diseases segment is anticipated to have lucrative growth during the forecast period. They minimize damage to healthy tissues and enable precise targeting of tumors. By specifically recognizing and binding to cancer cells, these nanoparticles can be engineered to enhance the drug's accumulation at the tumor site. Furthermore, these nanocarriers' special qualities allow for regulated drug release, resulting in long-lasting and targeted therapeutic effects. Because of their small size, they can penetrate tumor tissues and reach places that may be difficult for conventional medications to reach.
Region with largest share:
North America commanded the largest market share during the extrapolated period. Significant investments in research and development, in conjunction with a strong healthcare system, create an atmosphere that is favourable to innovative developments in nanotechnology. Leading biotech and pharmaceutical companies is present, which encourages teamwork and leads to the development of advanced drug delivery systems. Establishing a culture of innovation and discovery, academic institutions and research centers consistently contribute to technological breakthroughs in nanomedicine in this region.
Region with highest CAGR:
Europe is expected to witness profitable growth over the projection period, owing to its strong focus on research and development, Europe is a prominent hub for nanomedicine in drug delivery. This innovation is driven by nations like Germany, the UK, and Switzerland, which provide a rich environment for scientific research and technological development. The region is focused on cutting-edge methods, with a particular emphasis on precision medicine and customized treatments utilizing nanotechnology. Europe as a driving force in the evolution of advanced drug delivery systems, making it a crucial player in the global nanomedicine market.
Key players in the market
Some of the key players in the Nanomedicine for Drug Delivery Market include Camurus AB, Celgene, Inc., Eye Point Pharmaceuticals, EnColl Corporation, Cytimmune Sciences, Inc., Ceramisphere Health Pty Limited, Cristal Therapeutics, Aquanova AG, Blue Willow Biologics, AbbVie Inc., Amgen Foundation, Abbott, Cadila Pharmaceuticals , Novartis AG, Johnson & Johnson Services, Pfizer Inc., F. Hoffmann-La Roche Ltd and Eli Lilly and Company.
Key Developments:
In Dec 2022, Eli Lilly and Company and EVA Pharma announced a collaboration to deliver a sustainable supply of high-quality, affordable human and analogue insulin to at least one million people living with type 1 and type 2 diabetes in low-to middle income.
In Aug 2022, Abbott and WeightWatchers announced a strategic partnership that will help people living with diabetes better understand and manage their diabetes and weight.
In June 2022, Pfizer announces Strategic Collaboration with Truveta to Accelerate Safety Insights in Real Time. Truveta will provide Pfizer with an unprecedented data platform for research. The data collected by Truveta are always flowing, providing the most up-to-date picture of U.S. health.
Product Types Covered:
• Nanoparticles
• Nanoshells
• Nanodevices
• Nanotubes
Modalities Covered:
• Treatments
• Diagnostics
Indications Covered:
• Infectious Diseases
• Orthopedic Disorders
• Oncological Diseases
• Cardiovascular Diseases
• Urological Diseases
• Neurological Diseases
• Immunological Diseases
• Ophthalmological Diseases
• Other Indications
Route of Administrations Covered:
• Parenteral
• Oral
• Inhalation
• Topical
End Users Covered:
• Specialty Clinics
• Hospitals
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Nanomedicine for Drug Delivery Market, By Product Type
5.1 Introduction
5.2 Nanoparticles
5.2.1 Metal and Metal Oxide Nanoparticles
5.2.2 Liposomes
5.2.3 Hydrogel Nanoparticles
5.2.4 Polymers and Polymer Drug Conjugates
5.2.5 Dendrimers
5.2.6 Inorganic Nanoparticles
5.3 Nanoshells
5.4 Nanodevices
5.5 Nanotubes
6 Global Nanomedicine for Drug Delivery Market, By Modality
6.1 Introduction
6.2 Treatments
6.3 Diagnostics
7 Global Nanomedicine for Drug Delivery Market, By Indication
7.1 Introduction
7.2 Infectious Diseases
7.3 Orthopedic Disorders
7.4 Oncological Diseases
7.5 Cardiovascular Diseases
7.6 Urological Diseases
7.7 Neurological Diseases
7.8 Immunological Diseases
7.9 Ophthalmological Diseases
7.10 Other Indications
8 Global Nanomedicine for Drug Delivery Market, By Route of Administration
8.1 Introduction
8.2 Parenteral
8.3 Oral
8.4 Inhalation
8.5 Topical
9 Global Nanomedicine for Drug Delivery Market, By End User
9.1 Introduction
9.2 Specialty Clinics
9.3 Hospitals
9.4 Other End Users
10 Global Nanomedicine for Drug Delivery Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 Camurus AB
12.2 Celgene, Inc.
12.3 EyePoint Pharmaceuticals
12.4 EnColl Corporation
12.5 Cytimmune Sciences, Inc.
12.6 Ceramisphere Health Pty Limited
12.7 Cristal Therapeutics
12.8 Aquanova AG
12.9 BlueWillow Biologics
12.10 AbbVie Inc.
12.11 Amgen Foundation
12.12 Abbott
12.13 Cadila Pharmaceuticals
12.14 Novartis AG
12.15 Johnson & Johnson Services
12.16 Pfizer Inc.
12.17 F. Hoffmann-La Roche Ltd
12.18 Eli Lilly and Company
List of Tables
1 Global Nanomedicine for Drug Delivery Market Outlook, By Region (2021-2030) ($MN)
2 Global Nanomedicine for Drug Delivery Market Outlook, By Product Type (2021-2030) ($MN)
3 Global Nanomedicine for Drug Delivery Market Outlook, By Nanoparticles (2021-2030) ($MN)
4 Global Nanomedicine for Drug Delivery Market Outlook, By Metal and Metal Oxide Nanoparticles (2021-2030) ($MN)
5 Global Nanomedicine for Drug Delivery Market Outlook, By Liposomes (2021-2030) ($MN)
6 Global Nanomedicine for Drug Delivery Market Outlook, By Hydrogel Nanoparticles (2021-2030) ($MN)
7 Global Nanomedicine for Drug Delivery Market Outlook, By Polymers and Polymer Drug Conjugates (2021-2030) ($MN)
8 Global Nanomedicine for Drug Delivery Market Outlook, By Dendrimers (2021-2030) ($MN)
9 Global Nanomedicine for Drug Delivery Market Outlook, By Inorganic Nanoparticles (2021-2030) ($MN)
10 Global Nanomedicine for Drug Delivery Market Outlook, By Nanoshells (2021-2030) ($MN)
11 Global Nanomedicine for Drug Delivery Market Outlook, By Nanodevices (2021-2030) ($MN)
12 Global Nanomedicine for Drug Delivery Market Outlook, By Nanotubes (2021-2030) ($MN)
13 Global Nanomedicine for Drug Delivery Market Outlook, By Modality (2021-2030) ($MN)
14 Global Nanomedicine for Drug Delivery Market Outlook, By Treatments (2021-2030) ($MN)
15 Global Nanomedicine for Drug Delivery Market Outlook, By Diagnostics (2021-2030) ($MN)
16 Global Nanomedicine for Drug Delivery Market Outlook, By Indication (2021-2030) ($MN)
17 Global Nanomedicine for Drug Delivery Market Outlook, By Infectious Diseases (2021-2030) ($MN)
18 Global Nanomedicine for Drug Delivery Market Outlook, By Orthopedic Disorders (2021-2030) ($MN)
19 Global Nanomedicine for Drug Delivery Market Outlook, By Oncological Diseases (2021-2030) ($MN)
20 Global Nanomedicine for Drug Delivery Market Outlook, By Cardiovascular Diseases (2021-2030) ($MN)
21 Global Nanomedicine for Drug Delivery Market Outlook, By Urological Diseases (2021-2030) ($MN)
22 Global Nanomedicine for Drug Delivery Market Outlook, By Neurological Diseases (2021-2030) ($MN)
23 Global Nanomedicine for Drug Delivery Market Outlook, By Immunological Diseases (2021-2030) ($MN)
24 Global Nanomedicine for Drug Delivery Market Outlook, By Ophthalmological Diseases (2021-2030) ($MN)
25 Global Nanomedicine for Drug Delivery Market Outlook, By Other Indications (2021-2030) ($MN)
26 Global Nanomedicine for Drug Delivery Market Outlook, By Route of Administration (2021-2030) ($MN)
27 Global Nanomedicine for Drug Delivery Market Outlook, By Parenteral (2021-2030) ($MN)
28 Global Nanomedicine for Drug Delivery Market Outlook, By Oral (2021-2030) ($MN)
29 Global Nanomedicine for Drug Delivery Market Outlook, By Inhalation (2021-2030) ($MN)
30 Global Nanomedicine for Drug Delivery Market Outlook, By Topical (2021-2030) ($MN)
31 Global Nanomedicine for Drug Delivery Market Outlook, By End User (2021-2030) ($MN)
32 Global Nanomedicine for Drug Delivery Market Outlook, By Specialty Clinics (2021-2030) ($MN)
33 Global Nanomedicine for Drug Delivery Market Outlook, By Hospitals (2021-2030) ($MN)
34 Global Nanomedicine for Drug Delivery Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
